Lung cancer
Conditions
Interventions
Gold Standard:Paraffin pathological diagnosis after systematic mediastinal lymphadenectomy.
Index test:The 
selective 
mediastinal 
lymphadenectomy 
based 
on 
tumor 
ground-glass 
and 
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: All enrolled patients must meet the following criteria: 1) Patients who sign informed consent and are willing to complete the study according to the protocol; 2) There was no history of malignant tumor and no pulmonary surgery; 3) On CT, there were single or multiple tumors, but all the other lesions were pure ground glass nodules except the main one; 4) Patients with peripheral clinical stage of T1N0M0 were resectable; 5) Preoperative or intraoperative pathology confirmed invasive non-small cell lung cancer; 6) The initial treatment did not receive radiotherapy and chemotherapy; 7) Complete and systematic mediastinal lymph node dissection was performed.
Exclusion criteria
Exclusion criteria: Any of the following is the exclusion criteria for this study: 1) The clinical stage was not T1N0M0; 2) Complete surgical resection can not be performed; 3) It was confirmed by cytology or histopathology as adenocarcinoma in situ / microinvasive adenocarcinoma or other lung malignancies other than non-small cell lung cancer; 4) History of malignant tumor; 5) Patients who have received radiotherapy or chemotherapy; 6) Patients who did not receive complete mediastinal lymph node dissection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the Staging Accuracy of a Selective Mediastinal Lymphadenectomy Strategy;SEN, SPE, ACC, AUC of ROC;consistency; | — |
Countries
China
Contacts
Public ContactZhang Yang
Fudan University Shanghai Cancer Center
Outcome results
None listed